IL90189A0 - Pharmaceutical compositions containing a benzazepine-type calcium channel blocker - Google Patents

Pharmaceutical compositions containing a benzazepine-type calcium channel blocker

Info

Publication number
IL90189A0
IL90189A0 IL90189A IL9018989A IL90189A0 IL 90189 A0 IL90189 A0 IL 90189A0 IL 90189 A IL90189 A IL 90189A IL 9018989 A IL9018989 A IL 9018989A IL 90189 A0 IL90189 A0 IL 90189A0
Authority
IL
Israel
Prior art keywords
benzazepine
pharmaceutical compositions
compositions containing
calcium channel
channel blocker
Prior art date
Application number
IL90189A
Other languages
English (en)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL90189A0 publication Critical patent/IL90189A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL90189A 1988-06-01 1989-05-04 Pharmaceutical compositions containing a benzazepine-type calcium channel blocker IL90189A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20317388A 1988-06-01 1988-06-01

Publications (1)

Publication Number Publication Date
IL90189A0 true IL90189A0 (en) 1989-12-15

Family

ID=22752815

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90189A IL90189A0 (en) 1988-06-01 1989-05-04 Pharmaceutical compositions containing a benzazepine-type calcium channel blocker

Country Status (8)

Country Link
EP (1) EP0344995A3 (fr)
JP (1) JPH0225422A (fr)
KR (1) KR900000082A (fr)
AU (1) AU607612B2 (fr)
DK (1) DK265789A (fr)
HU (1) HUT58521A (fr)
IL (1) IL90189A0 (fr)
ZA (1) ZA893735B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
US6300085B1 (en) 1993-05-03 2001-10-09 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic method for Alzheimer's disease
US5976816A (en) * 1993-05-03 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Cell tests for alzheimer's disease
DE60031171T2 (de) * 2000-01-26 2007-08-23 Astellas Pharma Inc. Ace inhibitor-vasopressin antagonist kombinationen
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
WO2005011736A1 (fr) * 2003-07-30 2005-02-10 Tohoku Techno Arch Co., Ltd. Medicament pour la prevention et/ou le traitement de la maladie d'alzheimer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4168267A (en) * 1978-10-23 1979-09-18 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl prolines
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4432971A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4504476A (en) * 1983-09-16 1985-03-12 Arnold Schwartz Method of administering calcium channel blocking agents
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
CA1321753C (fr) * 1987-04-27 1993-08-31 Abraham Sudilovsky Methode permettant d'empecher la perte des fonctions cognitives a l'aide d'un inhibiteur de l'enzyme de conversion
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like

Also Published As

Publication number Publication date
AU607612B2 (en) 1991-03-07
JPH0225422A (ja) 1990-01-26
KR900000082A (ko) 1990-01-30
DK265789A (da) 1989-12-02
DK265789D0 (da) 1989-05-31
EP0344995A3 (fr) 1990-12-05
ZA893735B (en) 1990-02-28
HUT58521A (en) 1992-03-30
EP0344995A2 (fr) 1989-12-06
AU3493089A (en) 1989-12-07

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
IL93996A0 (en) Pharmaceutical composition containing a liposome
GB8825892D0 (en) Pharmaceutical composition
EP0410422A3 (en) A highly absorbable pharmaceutical composition
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
IL87943A (en) Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
IL87921A (en) Pharmaceutical composition containing a piperidinoalkanol derivative together with calcium carbonate
AR243767A1 (es) Una composicion oral antibacterial para la higiene de la boca.
IL90189A0 (en) Pharmaceutical compositions containing a benzazepine-type calcium channel blocker
GB8814422D0 (en) Analgesic compounds & compositions
ZA893422B (en) Pharmaceutical composition
IL95588A0 (en) Pharmaceutical compositions containing paf-antagonists
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU8202287A (en) A water-swellable composition for water-leakage prevention
ZA916592B (en) A pharmaceutical composition
GB9018039D0 (en) A pharmaceutical composition
GB8808404D0 (en) Trimelamol-containing pharmaceutical compositions
IL89254A (en) Pharmaceutical compositions containing diaryl compounds
GB8910797D0 (en) A sealing composition
IE881715L (en) Anti-bacterial oral composition containing bis-biguanido¹hexanes
ZA893984B (en) Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
GB8818098D0 (en) Pharmaceutical composition
GB8802927D0 (en) Pharmaceutical composition
GB8818118D0 (en) Pharmaceutical composition